Post-COVID innovation: How U.S. medtech can capitalize on this moment
by Jeff Mirviss, President, Peripheral Interventions at Boston Scientific Note: This blog post first appeared in the Star
Three Use Cases for Real-World Data & Artificial Intelligence for Devices and Diagnostics
By Joseph Zabinski, PhD, Senior Director of AI & Precision Medicine, OM1 As innovation in devices and diagnostics
Moving the Needle
Note: This post originally appeared on AdvaMed.org on Oct. 30, 2020. AdvaMed Advance® recently hosted more than 200
The Nature of COVID-19: Impact and Recovery in US Hospitals
By Monish Rajpal, Jonas Funk and Ilya Trakhtenberg of L.E.K. Consulting In light of COVID-19, L.E.K. Consulting has
EY + AdvaMed MedTech CEO Roundtables
By Jim Welch, EY Global MedTech Leader, Health Sciences and Wellness On August 26, 2020, AdvaMed and EY
It’s Not About the Robot: Fully Realizing the Benefits of Digital Surgery
By Brian Chapman, Principal and Leader of ZS’s Medtech PracticeBrian Chapman is a principal in ZS’s Evanston office
RWD for Evaluating Device & Diagnostic Performance & Outcomes
by Richard Gliklich, MD, CEO of OM1 and Michelle Leavy, MPH, Head of Health Policy at OM1 Interest
